Portal de Periódicos da CAPES

Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations

2014; BMJ; Volume: 74; Issue: 1 Linguagem: Inglês

10.1136/annrheumdis-2014-205233

1468-2060

Zachary S. Wallace, Hamid Mattoo, Mollie N. Carruthers, Vinay S. Mahajan, Emanuel Della‐Torre, Hang Lee, Maria Kulikova, Vikram Deshpande, Shiv Pillai, John H. Stone,

Neuroendocrine Tumor Research Advances

We examined the utility of circulating total and IgG4+ plasmablasts as biomarkers of diagnosis and disease activity in IgG4-related disease (IgG4-RD).